Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XCJECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XCJECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XCJEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XCJEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XCJENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCJENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FT.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FT.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FT.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FT.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FT.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FT.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FT.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FT.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FZ.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FZ.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FZ.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FZ.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FZ.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FZ.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FZ.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.45EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.45ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.45ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.45EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.45EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.45ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.45ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.72EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.72EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.72ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.72ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.72EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.72EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.72ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.72ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.43EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.43ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.43ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.43EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.43EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.43ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.43ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.85EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.85EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.85ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.85ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used